Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,485 across all filing types
Latest filing 2020-02-07 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Director's Dealing 2020
Director's Dealing Classification · 100% confidence The document explicitly states it is a 'Report on transactions of executives and related parties in Coloplast shares and related securities' and references 'Market Abuse Regulation article 19'. This regulation mandates reporting of insider transactions by persons discharging managerial responsibilities (PDMRs). The content details the name of the executive (Thomas Barfod), their position (Member of the Board), the nature of the transaction ('Sale of shares'), and the specific price and volume. This perfectly matches the definition of Director's Dealing (insider trades).
2020-02-07 English
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction in Coloplast shares by a person with managerial responsibilities (a board member). It explicitly references Article 19 of the Market Abuse Regulation (MAR), which governs the reporting of insider dealings. This matches the definition for 'Director's Dealing' (DIRS).
2020-02-07 Danish
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 100% confidence The document title 'Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier' translates to 'Transactions in Coloplast shares by board members, directors, or closely related persons'. This is a standard notification for insider trading or director dealings. The document is very short and directs the reader to an attached PDF, which is characteristic of a notification filing.
2020-02-07 English
Coloplast A/S - Allocation of Share Options
Director's Dealing Classification · 100% confidence The document is a formal notification of transactions by persons discharging managerial responsibilities (PDMRs) at Coloplast A/S, specifically regarding the allocation of share options. It explicitly references Article 19 of the Market Abuse Regulation (MAR), which is the standard regulatory framework for reporting insider dealings. The document lists the names, positions, and transaction details (share options) for several executives and board members. This fits the definition of 'Director's Dealing' (DIRS).
2020-01-20 Danish
Coloplast A/S - Allocation of Share Options
Director's Dealing Classification · 100% confidence The document is a formal notification regarding transactions in Coloplast A/S shares and related securities by persons with managerial responsibilities (directors and executives). It explicitly references the Market Abuse Regulation (MAR) Article 19, which governs the disclosure of insider dealings. The content details specific allocations of share options to named executives and board members. While the document contains a link to an attachment, the text itself provides the full disclosure of the transactions, making it a primary 'Director's Dealing' (DIRS) filing rather than just an announcement of a report.
2020-01-20 English
Remuneration Information 2020
Remuneration Information Classification · 99% confidence The document explicitly states it is a 'Report on transactions of executives and related parties in Coloplast shares and related securities' and details the 'allocation of share options' to individuals holding managerial responsibilities (President & CEO, CFO, EVPs, Chairman of the Board). This type of filing, mandated by the Market Abuse Regulation (MAR) Article 19, reports personal share transactions by company directors and executives (insider trades). This directly matches the definition for Director's Dealing (DIRS). Although it involves options, the core purpose is reporting insider transactions, not general capital changes (SHA) or remuneration details (DEF 14A).
2020-01-20 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.